Acute fever without a focus in infants and children
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
NICE version — no FBC or CRP in the community (3 months or older, without severity signs)
Urine tests (before any antibiotic)
- Urine dipstick (in the practice, on midstream urine if possible)
- Urine microscopy and culture (if leucocytes or nitrites positive on the dipstick, or if intermediate risk of serious illness)if needednon-French guidelineNICE says to send urine for culture if the dipstick shows leucocytes or nitrites, in suspected pyelonephritis, intermediate or high risk of serious illness, recurrent urinary tract infections, or discordance between the clinical picture and the dipstick [2]. Collect before any antibiotic [2].
Also consider
- Fever without a focus, urinary signs? For unexplained fever or urinary signs, see the page "Infection urinaire de l'enfant" (treatment and follow-up).
Do not order
Alternative version — if tests are considered
- Does not replace clinical assessment (NICE traffic-light system) or paediatric opinion: result to be obtained the same day, child re-examined at a set time with the result.
Laboratory tests (the same day)
- FBC (if laboratory tests are chosen: see the situations in the note)if needednon-French guidelineInfant aged 61 to 90 days in good general condition who is not being referred: the Canadian Paediatric Society accepts FBC, CRP or procalcitonin, blood culture and urinalysis to stratify risk [7]. “Amber” child aged 3 months or over: one of the tests that NICE has done in a paediatric setting [3].
- CRP (if laboratory tests are chosen: see the situations in the note)if needednon-French guideline“Amber” child when paediatric advice cannot be reached: in Belgian general practice, a CRP < 5 mg/L ruled out serious infection, but 3 of the 7 serious infections had a CRP < 20 mg/L (trial, not a recommendation) [8]. Prolonged fever in an infant under 6 months: documented inflammation with no other cause raises suspicion of incomplete Kawasaki disease [9]. Under 3 months, low-risk criterion: CRP ≤ 20 mg/L (Step-by-Step method) [7].
- Procalcitonin (infant under 3 months, if available the same day)if needednon-French guidelineInfant aged 90 days or less: marker of choice when available; low risk if < 0.5 ng/mL (Step-by-Step method, 22 to 90 days) or ≤ 1.71 ng/mL (PECARN rule) [7]. NICE does not mention it in the older child [3].
Urine tests (before any antibiotic)
- Urine microscopy and culture (infant under 3 months, even if the dipstick is negative)if needednon-French guidelineEvery febrile infant aged 90 days or less must have urinalysis and urine culture [7]; from 61 to 90 days, this is the minimum asked for by the Canadian Paediatric Society [7]. After 3 months, see the dipstick in the “NICE version” tab.
Also consider
Do not order
- FBC and CRP in a febrile child without signs of severity (“green” group): not recommended [3].
- CRP or procalcitonin alone to decide not to refer an infant aged 90 days or less: the markers are part of a full stratification and are never used alone [7].
- Interpreting a CRP between 5 and 20 mg/L as reassuring in an “amber” child: in the Belgian trial, 3 of the 7 serious infections had a CRP < 20 mg/L [8].
Infant under 3 months: paediatric emergency department, no tests in the community
- Fever ≥ 38 °C before 3 months: refer the same day to the paediatric emergency department, without prior tests in the community.
- The tests (FBC, CRP or procalcitonin, blood culture, urine microscopy and culture, lumbar puncture depending on age and risk) are done in hospital.
Do not order
- FBC, CRP or procalcitonin in primary care to decide not to refer: in the febrile infant, these markers improve risk stratification but must not be used alone; they are part of a hospital assessment [7].
Severity sign ("red") or purpura: emergency department
- Life-threatening sign or spreading purpura: call the emergency medical service (SAMU, 15); no sampling should delay treatment.
- "Red" sign without immediate threat to life: urgent paediatric opinion (paediatric emergency department), without prior tests in the community.
Fever after return from a malaria-endemic area
Urgent laboratory tests, the same day
- Blood film and thick film (or rapid diagnostic test combined with the blood film): malaria screen
- FBC with platelets
- State on the request form the country and the date of return, and the malaria chemoprophylaxis or treatment taken. The result must be returned within 4 hours of sampling: if this is not possible, refer to the paediatric emergency department.
12 to 24 hours later, if the first result is negative or doubtful
- Blood film and thick film (or rapid diagnostic test combined with the blood film): repeat malaria screenif neededFirst result negative or doubtful while malaria remains possible: the combination of blood film and rapid diagnostic test does not have optimal sensitivity, and the diagnosis must be repeated 12 to 24 hours later [11].
Sources (13)
- Boivin JM, Weber F, Fay R, Monin P. Prise en charge de la fièvre de l'enfant : les connaissances et pratiques des parents sont-elles satisfaisantes ? Arch Pediatr. 2007;14(4):322-9.
- National Institute for Health and Care Excellence. Urinary tract infection in under 16s: diagnosis and management. NICE guideline NG224, 27 juillet 2022.
- National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. NICE guideline NG143, 7 novembre 2019, mise à jour du 26 novembre 2021.
- Haute Autorité de santé. Prise en charge de la fièvre chez l'enfant. Fiche mémo, octobre 2016.
- Hamilton JL, Evans SG, Bakshi M. Management of Fever in Infants and Young Children. Am Fam Physician. 2020;101(12):721-729.
- The Royal Children's Hospital Melbourne. Clinical Practice Guidelines : Febrile child. Guide approuvé par le Paediatric Improvement Collaborative (Victoria, Australie), dernière mise à jour octobre 2026.
- Burstein B, Lirette MP, Beck C, Chauvin-Kimoff L, Chan K. Management of well-appearing febrile young infants aged ≤90 days. Société canadienne de pédiatrie, document de principes. Paediatr Child Health. 2024;29(1):50-66.
- Verbakel JY, Lemiengre MB, De Burghgraeve T, De Sutter A, Aertgeerts B, Shinkins B, et al. Should all acutely ill children in primary care be tested with point-of-care CRP: a cluster randomised trial. BMC Med 2016;14(1):131.
- Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, et al. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr 2018;44(1):102.
- Verbakel JY, Burvenich R, D'hulster E, De Rop L, Van den Bruel A, Anthierens S, et al. A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a pragmatic, cluster-randomised, controlled trial. Lancet 2025;406(10512):1599-1610.
- Société de pathologie infectieuse de langue française (SPILF), avec la Société française de pédiatrie (groupe de pédiatrie tropicale) et al. Prise en charge et prévention du paludisme d'importation. Mise à jour 2017 des recommandations pour la pratique clinique 2007.
- Leblanc C, Vasse C, Minodier P, Mornand P, Naudin J, Quinet B, et al. Management and prevention of imported malaria in children. Update of the French guidelines. Med Mal Infect. 2020;50(2):127-40.
- Lalloo DG, Shingadia D, Bell DJ, Beeching NJ, Whitty CJM, Chiodini PL ; PHE Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines 2016. J Infect. 2016;72(6):635-649.